Alpha-1 Antitrypsin Deficiency: Home Therapy

Anna Annunziata; Maurizia Lanza; Antonietta Coppola; Paolo Andreozzi; Sara Spinelli; Giuseppe Fiorentino

doi:10.3389/fphar.2021.575402

Frontiers in Pharmacology (Apr 2021)

Alpha-1 Antitrypsin Deficiency: Home Therapy

Anna Annunziata,
Maurizia Lanza,
Antonietta Coppola,
Paolo Andreozzi,
Sara Spinelli,
Giuseppe Fiorentino

Affiliations

Anna Annunziata: Department of Respiratory Pathophysiology Monaldi Hospital, Naples, Italy
Maurizia Lanza: Department of Respiratory Pathophysiology Monaldi Hospital, Naples, Italy
Antonietta Coppola: Department of Respiratory Pathophysiology Monaldi Hospital, Naples, Italy
Paolo Andreozzi: Gastroenterology Unit, Marcianise Hospital, Caserta, Italy
Sara Spinelli: Department of Respiratory Pathophysiology Monaldi Hospital, Naples, Italy
Giuseppe Fiorentino: Department of Respiratory Pathophysiology Monaldi Hospital, Naples, Italy

DOI: https://doi.org/10.3389/fphar.2021.575402
Journal volume & issue: Vol. 12

Abstract

Read online

While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by SARS-CoV2 infection. We assessed the safety of the home treatment and the quality of life of patients enrolled in the program.

Published in Frontiers in Pharmacology

ISSN: 1663-9812 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://journal.frontiersin.org/journals/pharmacology

About the journal

Abstract

Keywords